OVERVIEW

Each year, the Boston IBD conference  brings top gastroenterology specialists from North America together with up-and-coming Boston area specialists for a 1.5 day CME/CNE program. This program is designed to stimulate conversations about how to initiate practice changes within the IBD healthcare team in in the diagnosis and management of patients with Crohn's disease (CD) and ulcerative colitis (UC).  Through keynote talks, panel discussions and breakout sessions, you will be challenged to develop innovative strategies to improve the quality of life for your patients while prolonging clinical remission. The city of Boston provides an excellent backdrop for this educational and networking experience – we hope you can join us in person – or – if you prefer – from the comfort of your home or office through a virtual live stream. 

TARGET AUDIENCE

This course is designed for the  entire IBD healthcare team  including gastroenterologists, pediatric gastroenterologists, colorectal surgeons, NP/PAs, nurses. pharmacists and other health care professionals caring for patients with CD and UC.

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:
 

• Discuss emerging agents for IBD in terms of therapeutic target, safety and efficacy data, and place in therapy.
• Critically assess targets of mucosal healing used in treat-to-target strategies and the evidence that exists to support the use of these strategies in IBD patients.
• Differentiate the benefits and risks of biologic treatments in patients with IBD.
• Recognize the value and role of therapeutic drug monitoring.
• Explore the complex interplay of IBD and fertility concerns, pregnancy, and sexual function in women’s health. 
• Promote and advocate for the patient’s role and voice in IBD shared decision-making to drive a more patient-oriented treatment approach.
• Review the role of diagnostic imaging and endoscopic biopsy in the diagnosis and monitoring of CD and UC.
• Identify the most current approaches to the management of postoperative recurrence in CD.
• Describe the medical and surgical approaches in patients with severe UC and pouchitis.
• Identify issues specific to LGBTQ patients with IBD.

ACCREDITATION

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.